显微镜下多血管炎表型与临床结局的时序变化
该研究对比1980—2001年与2002—2022年两个时期诊断的显微镜下多血管炎(MPA)患者,发现后期患者年龄更大、肾功能更好、Berden硬化型比例更低,尽管患者生存率相似,但终末期肾病(ESKD)风险显著降低,复发风险数值上更高。
要点
- 2002—2022年诊断的MPA患者较1980—2001年更老、肾功能更好、硬化型比例更低。
- 2002—2022年ESKD风险显著低于1980—2001年(HR 0.30)。
- 两时期患者生存率无显著差异,复发风险数值上更高但未达统计学显著性。
核心结论
- 过去数十年MPA肾脏受累严重程度减轻,导致ESKD风险降低、复发率升高,而死亡风险相当。
研究设计与样本
- 研究纳入1980—2022年诊断的187例MPA患者,分为1980—2001年(77例)和2002—2022年(110例)两个时期进行比较。
- 采用Kaplan-Meier估计和Cox回归比较死亡率,采用Aalen-Johansen估计、Fine-Gray多元回归和多状态模型分析ESKD与死亡的竞争风险。
主要发现
- 2002—2022年组患者年龄66.2 ± 14.0岁,1980—2001年组57.7 ± 15.8岁(P < 0.001)。
- 2002—2022年组eGFR 25.9 ± 24.8 ml/min per 1.73 m2,1980—2001年组21.5 ± 28.2 ml/min per 1.73 m2(P = 0.011)。
- 2002—2022年组Berden硬化型比例为5.9%,1980—2001年组为20.9%(P = 0.011)。
- 2002—2022年组ESKD风险较1980—2001年组降低:亚分布HR 0.30(95%CI 0.16-0.57;P < 0.001)。
- 2002—2022年组复发风险数值上高于1980—2001年组:亚分布HR 1.64(95%CI 0.95-2.83;P = 0.075)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Diagnosis and management of microscopic polyangiitis (MPA) have evolved considerably over the past decades, but it is unknown whether clinical and histological presentation and patient and renal outcomes have changed accordingly. METHODS: We compared clinical and histopathological characteristic at diagnosis, risk of death, end-stage kidney disease (ESKD), and relapse rate in patients diagnosed with MPA between 1980 and 2022, after grouping them in 2 periods (p): p1980-2001 and p2002-2022. We compared the mortality rate between the 2 periods using Kaplan-Meier estimator and Cox-regression, and competing risks of ESKD and death using the Aalen-Johansen estimator, Fine-Gray multiple regression, and multistate models. RESULTS: Out of 187 patients, 77 were in p1980-2001 and 110 in p2002 to 2022. Patients in p2002 to 2022 were older (66.2 ± 14.0 SD vs. 57.7 ± 15.8; P < 0.001), had a better kidney function (estimated glomerular filtration rate [eGFR] 25.9 ± 24.8 vs. 21.5 ± 28.2 ml/min per 1.73 m2; P = 0.011) and a lower prevalence of the Berden sclerotic class (5.9 vs. 20.9%; P = 0.011). Despite a similar crude and adjusted patient survival, the risk of ESKD decreased during p2002 to 2022 (subdistribution hazard ratio [HR] 0.30, 95% confidence interval [CI]: 0.16-0.57; P < 0.001). The results remained significant after accounting for death after ESKD and after adjusting for potential confounders (HR 0.33 [95% CI: 0.18-0.63; P < 0.001]). The risk of relapse was numerically higher during p2002 to 2022 (subdistribution-HR 1.64 [95% CI: 0.95-2.83; P = 0.075]). CONCLUSION: MPA kidney involvement has become less severe over the past decades, leading to a reduced risk of ESKD and a higher relapse rate, despite a comparable risk of death.
引用
- Uzzo M, Maggiore U, Sala F, et al. Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis. Kidney Int Rep. 2023. PMID: 37850011. doi:10.1016/j.ekir.2023.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。